Pharma Business review is using cookies

Continue Learn More

Close

Production & Sales - Marketing & Sales

20 Sep 2018
- Production & Sales
- Marketing & Sales
Norgine to commercialize Shield’s iron deficiency therapy in Europe, Australia and New Zealand

By PBR Staff Writer

Shield Therapeutics and Norgine have entered into an exclusive licence agreement in Europe, Australia and New Zealand, under which Norgine will commercialise Feraccru, Shield’s approved product for the treatment of iron deficiency in adults.
06 Jun 2017
Production & Sales
Marketing & Sales
Perrigo CEO to retire, search committee created to find replacement

By admin

Perrigo said its current CEO John Hendrickson is retiring and it has started a search for a replacement.
13 Feb 2017
Production & Sales
Marketing & Sales
Sanofi agrees to divest five OTC products to Ipsen for EUR83m

By PBR Staff Writer

Sanofi has agreed to divest five of its over-the-counter consumer healthcare products in Europe to French pharma firm Ipsen for €83m.